A basic fibroblast growth factor improves lower extremity wound healing with a porcine-derived skin substitute

Journal of Trauma - Injury, Infection and Critical Care

Volumn 64, Issue 3, 2008, Pages 809-815

  Akita, Sadanori ^a   Akino, Kozo ^a   Tanaka, Katsumi ^a   Anraku, Kuniaki ^a   Hirano, Akiyoshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Artificial dermis; Basic fibroblast growth factor; Lower extremity tissue defect; Quality of wound healing

Indexed keywords

RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMIDITY METER; LEG INJURY; MALE; PLASTIC SURGERY; PRIORITY JOURNAL; SKIN WATER LOSS; SPLIT THICKNESS SKIN GRAFT; TREATMENT OUTCOME; WATER CONTENT; WOUND CLOSURE; WOUND HEALING;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; LEG ULCER; MALE; MIDDLE AGED; SKIN, ARTIFICIAL; SWINE; TREATMENT OUTCOME; WOUND HEALING;

EID: 40549136469     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e31802c8247     Document Type: Article

References (29)

1. Henke PK, Blackburn SA, Wainess RW, et al. Osteomyelitis of the foot and toe in adults is a surgical disease: conservative management worsens lower extremity salvage. Ann Surg. 2005;241:885-892.
2. Khammash MR, Obeidat KA. Prevalence of ischemia in diabetic foot infection. World J Surg. 2003;27:797-799.
3. Patel GK. The role of nutrition in the management of lower extremity wounds. Int J Low Extrem Wounds. 2005;4:12-22.
4. Kauffman CA, Lahoda LU, Cederna PS, et al. Use of soleus muscle flaps for coverage of distal third tibial defects. J Reconstr Microsurg. 2004;20:593-597.
5. Maloney CT Jr, Wages D, Upton J, et al. Free omental tissue transfer for extremity coverage and revascularization. Plast Reconstr Surg. 2003;111:1899-1904.
6. Thomas TA, Taylor SM, Crane MM, et al. An analysis of limb-threatening lower extremity wound complications after 1090 consecutive coronary artery bypass procedures. Vas Med. 1999;4:83-88.
7. Hom DB, Manivel JC. Promoting healing with recombinant human platelet-derived growth factor-BB in a previously irradiated problem wound. Laryngoscope. 2003;113:1566-1571.
8. Palmer-Kazen U, Wariaro D, Luo F, et al. Vascular endothelial cell growth factor and fibroblast growth factor 2 expression in patients with critical limb ischemia. J Vasc Surg. 2004;39:621-628.
9. Steed DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group. J Vasc Surg. 1995;21:71-78.
10. Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care. 1998;21:822-827.
11. Nayeri F, Olsson H, Peterson C, et al. Hepatocyte growth factor; expression, concentration and biological activity in chronic leg ulcers. J Dermatol Sci. 2005;37:75-85.
12. Bianchi L, Ginebri A, Hagman JH, et al. Local treatment of chronic cutaneous leg ulcers with recombinant human granulocytemacrophage colony-stimulating factor. J Eur Acad Dermatol Venereol. 2002;16:595-598.
13. Cruciani M, Lipsky BA, Mengoli C, et al. Are granulocyte colony-stimulating factors beneficial in treating diabetic foot infections? A meta-analysis. Diabetes Care. 2005;28:454-460.
14. Fu X, Shen Z, Guo Z, et al. Healing of chronic cutaneous wounds by topical treatment with basic fibroblast growth factor. Chin Med J (Engl). 2002;115:331-335.
15. Richard JL, Parer-Richard C, Daures JP, et al. Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study. Diabetes Care. 1995;18:64-69.
16. Ferguson MW, O'Kane S. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc Lond B Biol Sci. 2004;359:839-850.
17. Hsu M, Peled ZM, Chin GS, et al. Ontogeny of expression of transforming growth factor-beta 1 (TGF-beta 1), TGF-beta 3, and TGF-beta receptors I and II in fetal rat fibroblasts and skin. Plast Reconstr Surg. 2001;107:1787-1794.
18. Beanes SR, Dang C, Soo C, et al. Down-regulation of decorin, a transforming growth factor-beta modulator, is associated with scarless fetal wound healing. J Pediatr Surg. 2001;36:1666-1671.
19. Suzuki S, Kawai K, Ashoori F, et al. Long-term follow-up study of artificial dermis composed of outer silicone layer and inner collagen sponge. Br J Plast Surg. 2000;53:659-666.
20. Muneuchi G, Suzuki S, Moriue T, et al. Combined treatment using artificial dermis and basic fibroblast growth factor (bFGF) for intractable fingertip ulcers caused by atypical burn injuries. Burns. 2005;31:514-517.
21. Ito K, Ito S, Sekine M, et al. Reconstruction of the soft tissue of a deep diabetic foot wound with artificial dermis and recombinant basic fibroblast growth factor. Plast Reconstr Surg. 2005;115:567-572.
22. Kawai K, Suzuki S, Tabata Y, et al. Accelerated wound healing through the incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis using a pressure-induced decubitus ulcer model in genetically diabetic mice. Br J Plast Surg. 2005;58:1115-1123.
23. Akita S, Akino K, Imaizumi T, et al. A basic fibroblast growth factor improved the quality of skin grafting in burn patients. Burns. 2005;31:855-858.
24. Akita S, Tanaka K, Hirano A. Lower extremity reconstruction after necrotizing fasciitis and necrotic skin lesions using a porcine-derived skin substitute. J Plast Reconstr Aesthet Surg. 2006;59:759-763.
25. Akita S, Akino K, Imaizumi T, et al. A polyurethane dressing is beneficial for split-thickness skin-graft donor wound healing. Burns. 2006;32:447-451.
26. Kanematsu A, Marui A, Yamamoto S, et al. Type I collagen can function as a reservoir of basic fibroblast growth factor. J Control Release. 2004;99:281-292.
27. Imokawa G, Abe A, Jin K, et al. Decrease level of ceramides in stratum corneum of atopic dermatitis. J Invest Dermatol. 1991;96:523-526.
28. Rahban SR, Garner WL. Fibroproliferative scars. Clin Plast Surg. 2003;30:77-89.
29. Tagami H, Yoshikuni K. Interrelationship between water-barrier and reservoir functions of pathologic stratum corneum. Arch Dermatol. 1985;121:642-625.